Showing posts with label waiting lists. Show all posts
Showing posts with label waiting lists. Show all posts

Thursday, August 20, 2026

Fireside Chat Retreat in Pittsburgh, PA Tackles Emerging Crisis Facing AIDS Drug Assistance Programs

By: Brandon M. Macsata, CEO, ADAP Advocacy & Marcus J. Hopkins, Health Policy Lead Consultant, ADAP Advocacy

ADAP Advocacy hosted its Health Fireside Chat retreat in Pittsburgh, Pennsylvania, with key stakeholder groups to discuss the adverse impact on patient care caused by the emerging financial crisis facing state AIDS Drug Assistance Programs (ADAP). The Health Fireside Chat was held on Friday, August 14th, and convened as part of its grassroots advocacy campaign, 'ADAP Saves Lives: End the Wait', in response to the resurfacing of ADAP waiting lists—now affecting over 1,000 clients. Nearly two dozen diverse health policy stakeholders attended the event.

President Franklin D. Roosevelt
Photo Source: Getty Images

The ADAP Crisis discussion —including waiting lists in two states, cost containment measures in over one dozen states, a summary of the fiscal health and stress of the programs nationwide, and patient fears over not having access to their medications—was designed to capture key observations, suggestions, and thoughts about how best to address the challenges being discussed at the Health Fireside Chat. The following represents the attendees:

  • Kate Abel, Merck
  • Michelle Anderson, Narrative Power Institute LLC (ADAP Advocacy consultant)
  • Guy Anthony, Black, Gifted & Whole Foundation (ADAP Advocacy Board Co-Chair)
  • Scott Bertani, HealthHIV
  • Duane Binion, True T Pittsburgh
  • Erin Bradshaw, Patient Advocate Foundation
  • Jeffrey S. Crowley, O’Neill Institute
  • Jose De Marco, ACT UP Philadelphia
  • Moira Foster, Pennsylvania Department of Health, Division of HIV Health
  • John Haines, Pennsylvania Department of Health, ADAP
  • Kathie Hiers, AIDS Alabama (retired)
  • Marcus J. Hopkins, Appalachian Learning Initiative (ADAP Advocacy consultant)
  • Tim Horn, NASTAD
  • Amanda Kornegay, Kornegay Consulting LLC (ADAP Advocacy consultant)
  • Stephanie Knupsky, PWN Pennsylvania
  • Brandon M. Macsata, ADAP Advocacy
  • Tom McDaniels, HIV-HEP Policy Institute
  • Judith Montenegro, Latino Commission on AIDS
  • Steve Novia, ViiV Healthcare
  • Michiel Peters, Global Coalition on Aging
  • David Spears, Magic Box LLC (ADAP Advocacy consultant)

Health Fireside Chat

To level set and provide background for discussions, attendees are sent suggested readings in advance. The following are just a few from the thorough list provided for this session:

ADAP Advocacy is pleased to share the following brief recap of the Health Fireside Chat:

The Health Fireside Chat focused on the issues facing the nation's state AIDS Drug Assistance Programs (ADAP), with special attention to how the funding paradigm has shifted over the past 20 years.

Tim Horn speaking
Photo Source: ADAP Advocacy

[Tim Horn, right, and Steve Novis, left]

Tim Horn, Director of Medication Access at the National Alliance of State and Territorial AIDS Directors (NASTAD), led the discussion and presented data from state ADAPs to NASTAD for calendar year 2025. While these data won't be published until 2027, Horn explained that they point to trouble ahead:

  • Enrollment in state ADAP has increased, likely due to a combination of the introduction of the Ending the HIV Epidemic (EHE) program and the ending of the Medicaid Continuous Enrollment provision introduced during the COVID-19 pandemic to ensure that patients were not disenrolled
  • Per-client drug expenditures have increased 1.5% annually from 2019 to 2025
  • Per-client insurance premium expenditures have increased 8.3% annually from 2019 to 2025, and increased by 22% from Quarter 1 2025 to Quarter 1 2026. Double-digit increases are expected again in 2027
  • Despite a decrease in enrollment from 2024 to 2025, costs increased in prescription drug costs (2.6%), premium expenditure (17.1%), and total core expenditures (3.0%)
  • From 2019 to 2025, per-client costs increased 9.6%, and per-client insurance premiums increased 61.3%. Total spending increased 55.7%
Horn also explained that the ~$75 million in ADAP Emergency Funds have remained stagnant for several years, but the number of state ADAPs applying has increased from an average of ~8 states each year to 34, making that $75 million significantly less impactful.

Additionally, federal ADAP funding has remained unchanged at $900 million per year since 2014, even as the program costs $2.4 billion annually. Most state ADAPs cover that difference through 340B Drug Pricing Program rebates, which now account for 52% of ADAP budgets.

This reliance on rebate funding places state ADAPs in the precarious position of relying upon private industries to essentially fund a government program.

Of significant concern to Horn is the fact that there is no specific carveout for Persons Living with HIV/AIDS (PLWHA) in the Medicaid work requirements imposed by the federal government, meaning that PLWHA who are currently enrolled in state Medicaid programs may be kicked off of Medicaid for being unable to work or overcome the significant administrative (paperwork) burden placed upon them in order to prove that they are meeting the work requirements.

This shift in Medicaid policy is likely to result in PLWHA falling back on state ADAPs as they are disenrolled from Medicaid, further straining already limited budgets.

Horn also highlighted that the shift to purchasing health insurance for clients, once heralded as a significant cost-saving measure for state ADAPs compared with the direct purchasing model, is becoming less cost-effective as premiums, deductibles, and co-pays increase.

After Horn's initial presentation, attendees discussed their myriad concerns about the state of ADAP and access to HIV care. Stephanie Knupsky of Positive Women's Network PA summed it up best:

"I am scared. I listen to [Tim Horn's data] and all I can think about is how it feels like our voices are being suffocated."

Fear, in fact, was one of the primary sentiments expressed at the Pittsburgh FSC. How was the fear summarized during the day's discussions? 
  • Fear that the Trump Administration and MAGA Republicans are purposely trying to destroy social safety net programs like Medicaid, SNAP, and ADAP;
  • Fear that Black and Brown Americans are being specifically slandered and targeted in an attempt to instill so much fear in them that they stop attempting to enroll in these programs;
  • Fear that immigration policies are going to result in even worse health outcomes for non-White populations;
  • Fear that patients will fall out of care and services;
  • Fear that the loss of access to HIV medications could result in the emergence of multidrug-resistant strains of the HIV virus;
  • Fear that the loss of the current generation of HIV advocates and activists has left younger replacements insufficiently trained and prepared to pick up the mantle when they have retired or passed away.
Some patient advocacy organizations, such as HealthHIV, ACT UP Philly, and AIDS Alabama, offered additional historical perspectives from the last ADAP Crisis. It was noted that the Positive Women's Network (PWN) was in its infancy during the last go-around, but today it stands in a much stronger position to help shape the public debate.

Scott Bertani speaking
Photo Source: ADAP Advocacy

[Scott Bertani, right, Brandon M. Macsata, center, Marcus J. Hopkins, left]

ADAP Advocacy shared details about the re-activation of its grassroots advocacy campaign, "ADAP Saves Lives: End the Wait," including the airing of its new digital public service announcement (PSA). The latest PSA builds on the landmark PSA – which aired on 210 media outlets from February 21, 2011 to April 3, 2011.

The newly released PSA features Texas-based HIV-positive advocate Michelle Anderson, who was among the advocates included in the 2011 PSA. It can be viewed online here: https://www.youtube.com/watch?v=jxt-RuYqWE8.

Additionally, ADAP Advocacy announced the launch of its new grassroots advocacy hub, available online here: https://www.adapadvocacy.org/adap-saves-lives. Presently, it showcases the two states with waiting lists, Iowa and Utah, as well as four other states being monitored by the organization. Those states include Florida, Illinois, Pennsylvania, and Texas. The grassroots advocacy hub will add more resources and tools to help patient advocates in those states, and the broader advocacy campaign is also building out state advocacy teams.

For advocates in Pennsylvania, representatives from ACT UP Philly and PWN Pennsylvania shared updates on their work, and much of the conversation focused on improving coordination among the groups. ADAP Advocacy pushed the narrative that all the bubbling fear among PLWHA needed to be channeled into advocacy, as it was during the previous ADAP Crisis.

Not all sentiments were fearful, however. One of the comments most frequently made by attendees was how surprised they were that ADAP Advocacy chose to bring a Fireside Chat event to Pittsburgh:

"So often, we have to travel elsewhere to attend these meetings. Everyone goes to Philadelphia, which might as well be another planet compared to the rest of Pennsylvania. We need more of these kinds of meetings in Pittsburgh."

And this is the clarion call for advocacy organizations:

So often, we focus on hosting events in large cities—New York, San Francisco, Atlanta, Chicago, Boston, Washington, DC—because they are easier and more convenient to reach by transportation.

This tendency reflects arguably the greatest disparity in public health:

The worst health outcomes in the U.S. rarely occur in our nation's major cities; instead, they lie in smaller cities, rural areas, and geographically isolated regions.

While we regularly speak of rural hospital closures and a lack of access to quality healthcare services in underserved areas, we rarely host meetings and conferences there. This inevitably excludes the patient voices we most need to hear, as they cannot afford to travel to those major cities without significant financial and time outlays. It's food for thought, as organizations plan these events.

Additional Health Fireside Chats are planned for 2026.

Disclaimer: All funders of the ADAP Advocacy Association are publicly listed on our website


Disclaimer: Guest blogs do not necessarily reflect the views of the ADAP Advocacy Association; rather, they provide a neutral platform for the author to promote open, honest discussion of public health-related issues and updates.

Thursday, May 14, 2026

The ADAP “Perfect Storm” Returns; Over 1,000 Patients Being Denied Care

By: Marcus J. Hopkins, Health Policy Lead Consultant, ADAP Advocacy

What’s old is new, again! The “Perfect Storm” that confronted state AIDS Drug Assistance Programs for nearly a decade and resulted in patients living with HIV/AIDS being denied access to care is now the reality…again! 


According to the National Alliance of State and Territorial AIDS Directors (NASTAD), two states—Iowa and Utah—have implemented waiting lists for their ADAPs, becoming the first to do so in thirteen years. 1,106 patients living with HIV/AIDS are impacted in Iowa, and another 10 in Utah (NASTAD, 2026b).


Two ADAPs report active waiting lists—the first ADAP waiting lists reported to NASTAD since the February 2026 ADAP Watch, which identified zero.
Photo Source: NASTAD

The reimplementation of waiting lists comes after 12 years of flat funding for ADAP at the federal level and 2 decades of declining state-level funding (NASTAD, 2026a). These conditions have been exacerbated with the passage of the One Big Beautiful Bill, which decimated the social safety net (Segal, 2025). 


ADAP waiting lists were commonplace in the 2000s and into the mid-2010s, with waiting list rosters reaching their peak in 2011, with 9,298 Persons Living with HIV/AIDS (PLWHA) impacted across eleven states (The Henry J. Kaiser Family Foundation, 2017). In 2003, eight patients died while on ADAP waiting lists, including 5 in Kentucky and three in West Virginia (Connolly, 2004).


The reality is that ADAP programs quite literally save lives.


Research published in Clinical Infectious Diseases found that, despite ADAPs serving less than 25% PLWHA in the United States, ADAP clients account for almost a third of the entire viral suppression rate, with viral suppression rates ranging from 81.2% to 91.4% for ADAP client, compared with the overall viral suppression rate of 60% to 66.3% (McManus et al., 2026).


While Iowa and Utah are the first to reintroduce waiting lists, they are unlikely to be the last, particularly given the Trump Administration’s proposed budget, which has been characterized as having an open disdain for federal healthcare and social assistance programs.


Trump yelling at reporters
Photo Source: Rolling Stone

In April 2026, the White House’s Fiscal Year 2027 Budget proposal calls for the wholesale elimination of the Housing Opportunities for Persons With HIV/AIDS (HOPWA) program, referring to the program as “…outdated by focusing on housing low-income, homeless, and at-risk HIV-positive individuals, as the prognosis and medical care for HIV have significantly improved since the 1990s” (Office of Management and Budget, 2026).


In addition to waiting lists, NASTAD’s April 2026 ADAP Watch also reported that 19 programs are facing budget deficits, citing the following reasons:

  • Increasing drug costs/expenditures per client
  • Increasing health insurance premium costs
  • The expiration of enhanced premium tax credits
  • Increasing client enrollment
  • Decreasing 340B drug pricing program rebate revenues, and
  • Changes in federal allocations or supplemental funding (NASTAD, 2026b)

Two states—Indiana and Utah—have also introduced ADAP enrollment caps, with Indiana capping enrollment at 4,500 patients and Utah at 225 full-pay clients in addition to the aforementioned waiting lists. The travesty happening to Floridians living with HIV/AIDS is an entirely different situation, with one HIV advocate calling it “an open season on people living with AIDS,” and another to pen her pre-obituary as a "protest" as that state attempts to kick thousands of patients off its ADAP services.


ADAP Saves Lives: End the Wait
Photo Source: ADAP Advocacy

Additional cost-containment measures, including the previously reported lowering of income eligibility thresholds across various states (Hopkins, 2026), are likely to be implemented in the coming year, with little end in sight unless federal and state legislators decide to reprioritize PLWHA.


ADAP Advocacy will continue to monitor and report on changes to ADAP waiting lists as new developments occur, as it is taking steps to launch a national advocacy campaign to confront them.


Disclaimer: All funders of the ADAP Advocacy Association are publicly listed on our website


Disclaimer: Guest blogs do not necessarily reflect the views of the ADAP Advocacy Association; rather, they provide a neutral platform for the author to promote open, honest discussion of public health-related issues and updates.

References:

[1] Connolly, C. (2004, May 20). States Offering Less Assistance For AIDS Drugs Federal Spending Is Up, but So Is Demand, Survey Finds. The Washington Post. https://www.washingtonpost.com/wp-dyn/articles/A41229-2004May19.html 

[2] Henry J. Kaiser Family Foundation, The (2017, August). AIDS Drug Assistance Programs (ADAPs). Menlo Park, CA: The Henry J. Kaiser Family Foundation: Fact Sheet. https://files.kff.org/attachment/Fact-Sheet-AIDS-Drug-Assistance-Programs

[3] Hopkins, M. J. (2026, March 26). Ryan White Programmatic Funding Balances on a Precarious Precipice. Nags Head, NC: ADAP Advocacy: Blog. https://adapadvocacyassociation.blogspot.com/2026/03/ryan-white-programmatic-funding.html

[4] McManus, K. A., Killelea, A., Rogers, E. Q., Liu, F., Horn, T., Steen, A., Keim-Malpass, J., Hamp, A., & Rogawski McQuade, E. T. (2026, March 25). State AIDS Drug Assistance Programs’ Contribution to the US Viral Suppression, 2015–2022. Clinical Infectious Diseases, ciag034. https://doi.org/10.1093/cid/ciag034

[5] National Alliance of State and Territorial AIDS Directors. (2026a). 2026 National Ryan White HIV/AIDS Program Part B ADAP Monitoring Project Annual Report: Stabilizing the Safety Net: Stewardship and Outcomes in a Volatile Landscape. Washington, DC: National Alliance of State and Territorial AIDS Directors. https://nastad.org/2026-rwhap-part-b-adap-monitoring-report

[6] National Alliance of State and Territorial AIDS Directors. (2026b, April). ADAP Watch: April 2026. Washington, DC: National Alliance of State and Territorial AIDS Directors: Resources: ADAP Watch. https://nastad.org/sites/default/files/2026-04/adap-watch-april-2026.pdf

[7] Office of Management and Budget. (2026). Budget of the U.S. Government. Washington, DC: Executive Office of the President: Office of Management and Budget. https://www.whitehouse.gov/wp-content/uploads/2026/04/budget_fy2027.pdf

[8] Segal, B. (2025, July 3). How the ‘One Big, Beautiful Bill’ Targets Medicare and Medicaid. GovFact.org. https://govfacts.org/money/social-safety-net/medicare-medicaid/how-the-one-big-beautiful-bill-targets-medicare-and-medicaid/

Thursday, March 26, 2026

Ryan White Programmatic Funding Balances on a Precarious Precipice

By: Marcus J. Hopkins, Health Policy Lead Consultant, ADAP Advocacy

When then becomes now. In 2013, a large group of HIV advocates, activists, care providers, community organizations, pharmaceutical companies, and patients living with HIV/AIDS (PLWHA) gathered in Washington, DC, to address what they saw as a crisis: that the Ryan White Cares Act would be reopened and gutted by the then-Republican-majority.


ADAP saves lives: end the wait
Photo Source: ADAP Advocacy

Those fears never came to pass, in no small part because of a mutual agreement to simply not mention that the act needed to be reauthorized because there was no sunset provision—a provision that automatically repeals or terminates a law—and just pray that it would be forgotten. Disagreements aside, stakeholders agreed that with no clear path ahead, the best strategy was “keeping our heads down and pray no one notices us,” as the late Bill Arnold summarized.


It’s now 2026, and once again, the specter of a collapse is once again upon us. This time, political inaction, combined with accusations of purported malfeasance, appears to be the culprit. What previously worked is no longer a viable option, since HIV-related services have been in the crosshairs since Elon Musk started gutting much of the safety-net under the guise of government “efficiency,” regardless of the harm being caused to patients, families, neighborhoods, and communities.


State AIDS Drug Assistance Programs (ADAPs) across the U.S. are facing unprecedented budgetary shortfalls, with multiple states opting to implement “cost containment” measures, including (but not limited to) cutting income eligibility levels, requiring in-person recertification, cutting formulary coverage, and introducing per-patient expenditure caps, in an effort to keep their programs open for as many people as possible (Hopkins, 2026). The HIV community has been in similar predicaments, such as the “ADAP Crisis” that impacted over 10,000 patients between 2010-2012, but something about this crisis just feels different.


Why?


Because the number of PLWHA continues to increase, while federal funding remains flat and state-level funding decreases. And they’re living longer


According to the most recent report from the National Alliance for State and Territorial AIDS Directors, an average of 52% of all state ADAP budgets is derived from pharmaceutical and manufacturer rebates (NASTAD, 2026). This is a significant change from 2008, when federal funding accounted for 51%, state funding for 21%, and rebates for 21% (Figure 1).


Figure 1 - Total ADAP Budget, By Source, FY1996–FY2024


Figure 1 - Total ADAP Budget, By Source, FY1996–FY2024
Photo Source: NASTAD, 2026

Meanwhile, state funding has decreased to just 4% across the country, while the federal funding has remained relatively flat for a decade. For many programs, this has the potential to spell doom, as baseline budgets make using a rebate model—where programs pay the list price of medications upfront and are reimbursed the difference between the list price and the 340B Drug Pricing Program purchase price—a precarious endeavor. If the funds aren’t available to front-load those purchases, how will the programs do so and continue to provide services?


The answer is increasingly looking to be, “They can’t.”


In addition to being hit hard by funding shortages, ADAP programs, which have been authorized to pay for enrollees’ commercial insurance premiums, deductibles, and co-pays rather than using a full-pay medication model, have been struggling to keep up with the exponential annual increases in insurance costs foisted upon patients as yet another result of political inaction and malfeasance.


Since 2014, the average premium for an Affordable Care Act (ACA) Marketplace benchmark plan has risen from $273/month to $625/month in 2026 (Figure 2).


Figure 2 - Marketplace Average Monthly Benchmark Premiums, 2014-2026


Figure 2 - Marketplace Average Monthly Benchmark Premiums, 2014-2026
Photo Source: KFF, 2026

These marketplace benchmark trends coincide with the aforementioned flat federal funding, decreasing state funding, and increased ADAP enrollment following the winddown of the expanded Medicaid access allowed during the COVID-19 pandemic, which led to a roughly 30% increase in enrollment from Calendar Year 2022 (CY2022) to CY2024 (NASTAD, 2026).


Essentially, as premiums become increasingly unaffordable, enrollees who had previously relied on Ryan White and ADAP for co-pay assistance while paying their own premiums have, due to rising costs, been forced to turn to ADAP for assistance with premiums, deductibles, and co-pays.


What Does This Portend?


None of these circumstances on their own would be ideal, but in combination, ADAPs are, for the first time in over 12 years, considering implementing waitlists for services.


For those who don’t remember, ADAPs once resorted to leaving patients in need of treatment on state waitlists to gain access to funding. Essentially, the only way to get access was for someone to become ineligible or die. Over 10,000 PLWHA languished on waiting lists in 13 states, and several of them died; the community pleaded for help.


The threat of these once again becoming a reality has prompted concerns about the collapse of the program altogether, with a recently released analysis projecting over 117,000 new HIV diagnoses over 5 years if the program ends, and an additional 68,000+ diagnoses if the program is interrupted for 2.5 years (Haelle, 2026). No clearer example exists than what is happening in Florida.


A recent analysis present at the Conference on Retroviruses and Opportunistic Infections (CROI) found that, should the Ryan White HIV/AIDS Program collapse, the projected number of new HIV diagnoses is likely to increased by 73% in 30 states, with the hardest hit states being Colorado, South Carolina, Missouri, Tennessee, Kentucky, Alabama, Illinois, and Wisconsin (Schnure et al., 2026).


What Can Be Done?


At this point, most state legislative sessions have ended or are winding down, essentially making the prospect of securing state-level funding an unlikely avenue. Additionally, given the Trump Administration and the current composition of Congress, there is little evidence that positive momentum can be built to secure additional federal funding.


NASTAD is pushing for a $175 million increase in the federal appropriation to address the shortfalls. NASTAD's recent policy brief reads: "Of the $175 million increase, $75 million should be allocated through the ADAP base funding awards, and $100 million should be added to the ADAP Emergency Relief Funding, bringing those awards to a total of $175 million."


In the meantime, policy experts, advocates, and activists are working behind the scenes to mitigate the current and impending funding disasters. ADAP Advocacy will continue to monitor and report on circumstances as they develop.


Disclaimer: Guest blogs do not necessarily reflect the views of the ADAP Advocacy Association; rather, they provide a neutral platform for the author to promote open, honest discussion of public health-related issues and updates.

References:

[1] Dawson, L. & Kates, J. (2026, March 02). Constrained Budgets Lead States to Restrict HIV Drug Access Through Ryan White. Washington, DC: KFF: HIV/AIDS. https://www.kff.org/hiv-aids/constrained-budgets-lead-states-to-restrict-hiv-drug-access-through-ryan-white/

[2] Haelle, T. (2026, February 27). Study Warns of Large Increase in New HIV Cases in U.S. if Ryan White Program Ends: Colorado and several Southern and Midwest states would see the biggest increases in incidence. New York, NY: MedPage Today: Meeting Coverage: CROI. https://www.medpagetoday.com/meetingcoverage/croi/120084

[3] Hopkins, M. J. (2026, March 12). NASTAD Releases 2026 ADAP Monitoring Report: Warning Signs Ahead. Nags Head, NC: ADAP Advocacy: Blog. https://adapadvocacyassociation.blogspot.com/2026/03/nastad-releases-2026-adap-monitoring.html

[4] KFF. (2026). Marketplace Average Monthly Benchmark Premiums. Washington, DC: KFF: State Health Facts: Affordable Care Act: Health Insurance Marketplaces. https://www.kff.org/affordable-care-act/state-indicator/marketplace-average-benchmark-premiums/?activeTab=graph&currentTimeframe=0&startTimeframe=12&selectedRows=%7B%22wrapups%22:%7B%22united-states%22:%7B%7D%7D%7D&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D

[5] National Alliance of State and Territorial AIDS Directors. (2026a). 2026 National Ryan White HIV/AIDS Program Part B ADAP Monitoring Project Annual Report: Stabilizing the Safety Net: Stewardship and Outcomes in a Volatile Landscape. Washington, DC: National Alliance of State and Territorial AIDS Directors. https://nastad.org/2026-rwhap-part-b-adap-monitoring-report

[6] National Alliance of State and Territorial AIDS Directors. (2026, February 27). ADAP Fiscal Year 2027 Funding Request. Washington, DC: National Alliance of State and Territorial AIDS Directors. https://nastad.org/resources/adap-fiscal-year-2027-funding-request

[7] Schnure, M., Forster, R., Jones, J. L., Lesko, C. R., Batey, D. S., Butler, I., Ward, D., Musgrove, K., Althoff, K. N., Jain, M. K., Gebo, K. A., Dowdy, D. W., Shah, M., Kasaie, P., & Fojo, A. T. (2026). HIV Incidence Could Rise by 73% in 30 States if Ryan White Ends: A Simulation Study, Abstract [Conference abstract]. 2026 Conference on Retroviruses and Opportunistic Infections, Denver, Colorado, United States. https://www.natap.org/2026/CROI/croi_100.htm

Friday, April 22, 2011

When will Washington come to the Rescue?


When President Barack Obama signed into law the Fiscal-Year 2011 appropriations law (H.R.1473), many programs didn't share the modest success achieved with the small funding increase for the AIDS Drug Assistance Programs ("ADAPs"). The law provides $885 million for ADAP. This is $25 million more than was obligated in FY10, after a $25 million transfer added supplemental funds to address waiting lists. The bill provides $8 million more than H.R.1 - which was the House-passed version. Whereas the ADAP Advocacy Association (aaa+) applauded the President and Congress for the small increase - especially since many other safety-net programs were cut or level-funded - it begs the question: How satisfied should ADAP stakeholders be with the result?

Yes, clearly we're grateful for the additional $48 million because it will alleviate the ongoing ADAP crisis, albeit temporarily. It was a grassroots victory more than a demonstration of leadership by the national HIV/AIDS organizations (including this one). But more needs to be done! More voices need to be heard! More people living with HIV/AIDS - especially those patients being directly impacted by the ADAP waiting lists - need to get involved!

At the time this blog is published, there are 7,885 people living with HIV/AIDS on ADAP waiting lists in 11 states. Among them, Arkansas with 56 people; Florida with 3,807 people; Georgia with 1,343 people; Idaho with 10 people; Louisiana with 894 people; Montana with 24 people; North Carolina with 178 people; Ohio with 341 people; South Carolina with 612 people; Virginia with 616 people; and Wyoming with 4 people. And that doesn't even include the "invisible waiting lists that stretch into the thousands of patients adversely impacted by other cost containment strategies.

Failure is NOT an option because lives hang in the balance.

In response, aaa+ – together with its Lead Sponsor AIDS Healthcare Foundation (“AHF”) and in coordination with the Community Access National Network (CANN) and Housing Works – is hosting its 2011 Annual Conference as an AIDS Drug Assistance Program Summit. This year’s conference theme is “ADAPs in Crisis: When will Washington come to the rescue,” which aims to assemble ADAP stakeholders from all of the various constituency groups – including patients, advocates, service providers, health care providers, pharmaceutical companies, allied health professionals, specialty pharmacies and others.

ADAPs are in crisis. The purpose is to identify key action steps to secure additional federal appropriations, programmatic reforms, and available public and private resources to alleviate the ongoing cost-containment strategies that are putting thousands of people living with HIV/AIDS on ADAP wait lists or program disenrollment.

Faced with the “Perfect Storm” that is being fueled by high unemployment, record number of uninsured, state budgetary cutbacks, high cost of medications and inadequate federal funding, there are a historic number of people being denied access to treatment. Without intervention from either the executive or legislative branch, several thousand people living with HIV/AIDS will be at risk of developing Opportunistic Infections (“OIs”), and thousands of others who are HIV-negative will be at greater risk of contracting the virus because their HIV-positive counterparts are more infectious when not taking Highly Active Anti-Retroviral Therapy (“HAART”). The conference provides an excellent opportunity to demonstrate the proven Return on Investment (“ROI”) of ADAPs.

To learn more, please visit http://www.adapadvocacyassociation.org/events.html.